Adding Chemo to Endocrine Therapy Increases Cognitive Impairment in HR+, HER2- Breast Cancer

Adding chemotherapy to endocrine therapy leads to greater cognitive impairment in postmenopausal patients with breast cancer, a study suggests.

Related Keywords

California ,United States ,San Antonio ,Texas ,Irvine ,Irene Kang , ,San Antonio Breast Cancer Symposium ,Hope Orange County ,